Dr. Reddys Laboratories Ltd.

BSE: 500124 | NSE: DRREDDY
Large Cap | Pharmaceuticals & Drugs
1175.55
-10.90 (-0.92%)
< Home < Back

Dr. Reddy’s Laboratories informs about press release

Date: 29-07-2024

Dr. Reddy’s Laboratories has informed that it enclosed a Press Release on ‘Dr. Reddy’s receives positive CHMP opinion from European Medicines Agency for its proposed Rituximab biosimilar’.

The above information is a part of company’s filings submitted to BSE.